Search results for “Retinal dystrophy” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 89 patents, we discovered top 16 key players by total patent application. Novartis AG, Editas Medicine, Inc., Axys Pharmaceuticals, Inc. are dominant in this area. They take 53.93% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 27
Editas Medicine, Inc.
Massachusetts, United States
Patent: 7
Axys Pharmaceuticals, Inc.
California, United States
Patent: 6
UCL Business Ltd.
United Kingdom
Patent: 6
Fondazione Telethon
Lombardia, Italy
Patent: 4
Acucela, Inc.
Washington, United States
Patent: 3
STARTUP
Oculogenex, Inc.
California, United States
Patent: 3
Institut National de la Santé et de la Recherche Médicale
France
Patent: 2
Senju Pharmaceutical Beijing Co. Ltd.
Beijing Shi, China
Patent: 2
Allergan, Inc.
California, United States
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 3 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Oculogenex, Inc.
California, United States
Patent: 3
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 21 patents applied in the last 5 years. We discover 11 most active companies in this area. The fast-growing Editas Medicine, Inc., University of Florida, UCL Business Ltd. take 52.38% of patent filing during this period.
Editas Medicine, Inc.
Massachusetts, United States
Patent: 4
University of Florida
United States
Patent: 4
UCL Business Ltd.
United Kingdom
Patent: 3
STARTUP
Oculogenex, Inc.
California, United States
Patent: 3
Institut National de la Santé et de la Recherche Médicale
France
Patent: 2
Novartis AG
Basel-Stadt, Switzerland
Patent: 2
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 1
Fondation Imagine
France
Patent: 1
Université de Montpellier I
France
Patent: 1
Regents of The University of Michigan
Michigan, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 21 patents in last 5 years, we discover 5 new entrants. Oculogenex, Inc., Assistance Publique des Hôpitaux de Paris SA, Fondation Imagine are the most active new entrants in this area.
STARTUP
Oculogenex, Inc.
California, United States
Patent: 3
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 1
Fondation Imagine
France
Patent: 1
Université de Montpellier I
France
Patent: 1
Regents of The University of Michigan
Michigan, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 39 patents, we discovered top 6 universities and scientific research institutions by total patent application. University of Strasbourg, The University of Southampton, Universidad Complutense de Madrid are dominant in this area. They take 87.18% of the total patent filing.
University of Strasbourg
France
Patent: 14
The University of Southampton
SOUTHAMPTON, United Kingdom
Patent: 2
Universidad Complutense de Madrid
Madrid, Spain
Patent: 1
University of Barcelona
Spain
Patent: 1
University of Santiago de Compostela
Asturias, Spain
Patent: 1
Louis Pasteur University
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: